期刊文献+

非酒精性脂肪性肝病与心血管疾病 被引量:4

原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)已成为发达国家和富裕地区最常见的肝病,美国成人患病率约为30%。过去认为NAFLD是良性病变,现认为部分患者可发展为肝硬化,且近年研究发现NAFLD与心血管疾病关系密切,NAFLD患者发生心血管疾病是影响其预后的重要因素之一。
作者 展玉涛
出处 《中华内科杂志》 CAS CSCD 北大核心 2007年第10期868-869,共2页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献13

  • 1McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol, 2006, 40: S17-29.
  • 2Lee DH, Silventoinen K, Hu G, et al. Serum gammaglutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women. Eur Heart J, 2006, 27:2170 - 2176.
  • 3Ruttmann E, Brant LJ, Concin H, et al.γ-Glutamyltransferase as risk factor for cardiovascular disease mortality : an epidemiological investigation in a cohort of 163 944 austrian adults. Circulation, 2005, 112 : 2130-2137.
  • 4Targher G, Bertolini L, Padovani R, et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in dietcontrolled type 2 diabetic patients. J Endocrinol Invest, 2006, 29: 55-60.
  • 5Brea A, Mosquera D, Martin E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol, 2005, 25 : 1045-1050.
  • 6Targher G, Bertolini L, Padovani R, et al. Increased prevalence of cardiovascular disease in type 2 diabetic patients with non- alcoholic fatty liver disease. Diabet Med, 2006, 23: 403-409.
  • 7Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes, 2005, 54 : 3541-3546.
  • 8Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow- up of patients with NAFLD and elevated liver enzymes. Hepatology, 2006, 44: 865-873.
  • 9Bradbury, Michael W. Lipid metabolism and liver inflammation. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol, 2006,290 : G194-G198.
  • 10杨丽霞,杨玉霞,齐峰,郭传明,石燕昆,王燕,王红.冠心病患者胰岛素抵抗与冠状动脉病变的相关性分析[J].中国临床医学,2006,13(4):533-534. 被引量:6

二级参考文献7

  • 1Reaven GM.Role of insulin resistence in human disease[J].Diabetes,1988,37:1595-1607.
  • 2Hanley AJ,William SK,Stem MP,et al.Homeostasis model assessment of insulin resistence in relation to the incidence of cardiovascular disease,the San Antonio Heart Study[J].Diabetes Care,2002,25:1177-1184.
  • 3Stem M P.Diabetes and Cardiovascular disease.The "common soil" hypothesis[J].Diabetes,1995,44:374-396.
  • 4Masanobu Y,Fumimaro T,Takayuki T,et al.Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance[J].Circ J,2004,68:47-52.
  • 5Robins ST.Cardiovascular disease with diabetes or the metabolic syndrome:should statins or fibrates be first line lipid therapy?[J].Curr Opin Lipidol,2003,14:575-583.
  • 6Nordt TK,Bode C,Sobel BE.Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin[J].Diabetologia,2001,44:1121-1124.
  • 7全国糖尿病防治协作组,潘孝仁,杨文英,刘娟,郑旭,王芃,刘铨之.1994年中国糖尿病患病率及其危险因素[J].中华内科杂志,1997,36(6):384-389. 被引量:424

共引文献5

同被引文献35

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 2杨辉,李瑜元,聂玉强,江庆澜,洪勇,沙卫红,石胜利.非酒精性脂肪性肝病患者脂联素基因表达的变化[J].中华消化杂志,2006,26(12):837-838. 被引量:3
  • 3范建高.正确认识脂肪肝的危害[J].中华全科医师杂志,2007,6(4):199-200. 被引量:25
  • 4中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南.中华肝脏病杂志,2006,14(2):161-161.
  • 5Angulo P. Obesity and nonaleoholie fatty liver disease [ J ]. Nutr Rev ,2007,65 ( SI ) : $57 - 63.
  • 6Grant LM, Lisker MM. Nonalcoholic fatty liver disease [ J ]. Ann Hepatol,2004,3 ( 3 ) : 93 - 99.
  • 7Bedogni G, Bellentani S. Fatty liver, how frequent is it and why [ J ]. Ann Hepatol,2004,3(2) : 63 -65.
  • 8Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China [ J ]. J Hepatol, 2005,43 ( 3 ) : 508 - 514.
  • 9Gupte P, Amarapurkar D, Agal S, et al. Non - alcoholic steatohepatitis in type 2 diabetes mellitus[ J ]. Gastroenterol Hepatol,2004,19 (8) : 854 - 858.
  • 10Methta K,van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants[ J]. Nutr Rev,2002, 60 ( 9 ) : 289 - 293.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部